UCHL1 anticorps
Aperçu rapide pour UCHL1 anticorps (ABIN3026781)
Antigène
Voir toutes UCHL1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Attributs du produit
- This antibody specifically reacts with a protein of 20-30 kDa, identified as UchL1 (Ubiquitin carboxyl-terminal hydrolase-1), or PGP9.5. Studies using UchL1 antibody have shown that expression is related to tumor progression, with high expression correlating with poor prognosis, making the protein a potentially useful marker for pancreatic and invasive colorectal cancer. A mutation in gene is believed to cause a form of Parkinson's disease.
-
Purification
- Protein G affinity chromatography
-
Immunogène
- Native protein from brain was used as the immunogen for this UchL1 antibody.
-
Isotype
- IgG2a kappa
-
-
-
-
Indications d'application
- The concentration stated for each application is a general starting point. Variations in protocols, secondaries and substrates may require the UchL1 antibody to be titered up or down for optimal performance.\. WB: 0.5-1 μg/mL,IF: 1-2 μg/mL
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 1 mg/mL
-
Buffer
- 1 mg/mL in 1X PBS, BSA free, sodium azide free
-
Agent conservateur
- Azide free
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Store the UchL1 antibody at 2-8°C (with azide) or aliquot and store at -20°C or colder (without azide).
-
-
- UCHL1 (Ubiquitin Carboxyl-terminal Esterase L1 (Ubiquitin Thiolesterase) (UCHL1))
-
Autre désignation
- UchL1 PGP9.5
-
Sujet
- This antibody specifically reacts with a protein of 20-30 kDa, identified as UchL1 (Ubiquitin carboxyl-terminal hydrolase-1), or PGP9.5. Studies using UchL1 antibody have shown that expression is related to tumor progression, with high expression correlating with poor prognosis, making the protein a potentially useful marker for pancreatic and invasive colorectal cancer. A mutation in gene is believed to cause a form of Parkinson's disease.
-
ID gène
- 7345
-
Pathways
- Feeding Behaviour
Antigène
-